|
Press Releases |
|
|
|
Friday, September 23, 2022 |
|
Malaysian Genomics Grows Presence in Thailand |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce today a series of collaborations to grow its customer base in Thailand as well as exploring opportunities for research and development (R&D) of new products and services. more info >> |
|
Wednesday, September 21, 2022 |
|
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah |
Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to report that the Group has signed a letter of intent (LOI) with the Faculty of Science and Natural Resources, Universiti Malaysia Sabah (UMS) and Rinani Genotec Sdn Bhd (Genotec) to collaborate on research and development (R&D) in genetics, and regenerative and alternative medicines. more info >> |
|
Tuesday, August 30, 2022 |
|
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue |
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, reported revenue of RM6.33 million for the fourth quarter ended 30 June 2022 (4Q 2022) compared with the loss of RM0.07 million in the corresponding quarter of the previous financial year (4Q 2021) on higher contribution from the biopharmaceutical business and continued organic growth of the genetic testing business. more info >> |
|
Monday, August 29, 2022 |
|
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a Memorandum of Understanding (MoU) to explore opportunities for the distribution of biopharmaceutical and genomics products and services with Ajlan & Bros Medical Company. more info >> |
|
Thursday, August 18, 2022 |
|
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU |
Malaysian Genomics Resource Centre Berhad's (Bursa: MGRC, 0155) wholly-owned subsidiary, MGRC Therapeutics Sdn. Bhd. signed a memorandum of understanding (MoU) with MAHSA Health Sdn Bhd to discuss the formation of a strategic partnership promoting practice-based education, research and knowledge exchange. more info >> |
|
Wednesday, July 20, 2022 |
|
UCrest Partners with Malaysian Genomics to Digitalize Genome Services Worldwide |
UCrest Berhad (ACE Market: 0005) and Malaysian Genomics Resources Centre Berhad, (ACE Market: 0155) announced today that they have signed a collaborative agreement to integrate genomic testing services into digital health platform, iMedic(TM), elevating healthcare services to the next level. more info >> |
|
Friday, July 15, 2022 |
|
Malaysian Genomics Appoints New Chairman |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Company has appointed Dato' Seri Dr Chen Chaw Min as the Independent Non-Executive Chairman of the Board of Directors. more info >> |
|
Wednesday, July 13, 2022 |
|
Malaysian Genomics Forms Partnership for Expansion in Saudi Arabia |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that it has entered into a strategic partnership with United Doctors Hospital (UDH) for collaboration in genomics and cell therapies. more info >> |
|
Friday, July 8, 2022 |
|
Malaysian Genomics Proposes Private Placement |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is proposing to undertake a private placement of up to 10% of its total number of issued shares or up to 12.42 million new placement shares at an issue price to be determined for third-party investors that will be identified later. more info >> |
|
Wednesday, July 6, 2022 |
|
Malaysian Genomics to Offer First-Ever Sports-Based Tests Specific to Southeast Asian Genetic Profiles |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that the Group's wholly-owned subsidiary, MGRC Therapeutics Sdn Bhd (MGRCT), is collaborating with Rinani Genotec Sdn Bhd (Genotec) to offer sports-based genetic tests. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
中国飞机租赁 (1848.HK) 2023年总收入稳步增长 经调整股东应占溢利涨超4倍
Mar 19, 2024 20:30 HKT/SGT
|
|
|
中國飛機租賃 (1848.HK) 2023年總收入穩步增長 經調整股東應占溢利漲超4倍
Mar 19, 2024 20:29 HKT/SGT
|
|
|
WonderFi Announces Expansion into Australia
Mar 19, 2024 20:09 HKT/SGT
|
|
|
CALC Announces 2023 Annual Results
Mar 19, 2024 19:38: JST
|
|
|
首登国际运动舞台,天韵国际联合健力宝成为2024赛季F1中国大奖赛「2024格子旗音乐嘉年华」赞助商及官方合作伙伴
Mar 19, 2024 19:03 HKT/SGT
|
|
|
首登國際運動舞台,天韻國際聯合健力寶成為2024賽季F1中國大獎賽「2024格子旗音樂嘉年華」贊助商及官方合作夥伴
Mar 19, 2024 19:02 HKT/SGT
|
|
|
Debut on the Global Sports Stage, Tianyun International Joining Jianlibao to be the joint sponsors and official partners of the "2024 Checkered Flag Music Carnival" of Formula 1 Chinese Grand Prix 2024
Mar 19, 2024 19:01 HKT/SGT
|
|
|
CALC Announces 2023 Annual Results
Mar 19, 2024 18:32 HKT/SGT
|
|
|
Hitachi Collaborates with NVIDIA to Accelerate Digital Transformation with Generative AI
Mar 19, 2024 19:11 JST
|
|
|
TANAKA Holdings, Verlegung des Hauptsitzes nach Kayaba-cho, dem Gründungsort des Unternehmens
Mar 19, 2024 18:00 HKT/SGT
|
|
|
英皇钟表珠宝2023年全年总收入增长31%,净利润上升35%
Mar 19, 2024 17:56 HKT/SGT
|
|
|
英皇鐘錶珠寶2023年全年總收入增長31%,淨利潤上升35%
Mar 19, 2024 17:55 HKT/SGT
|
|
|
Emperor W&J 2023 Full Year Total Revenue Grows 31%, Net Profit Increases 35%
Mar 19, 2024 17:54 HKT/SGT
|
|
|
K-pop Boy Band, xikers, K-beauty NACIFIC Body & Hair Ambassador
Mar 19, 2024 17:30: JST
|
|
|
K-pop Boy Band, xikers, K-beauty NACIFIC Body & Hair Ambassador
Mar 19, 2024 16:30 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|